Posted in | News

Tecnalia Research and Innovation Develops Innovative Door for People with Low Mobility

As part of the Saleme project, Tecnalia Research and Innovation is participating with other Spanish companies such as Tesa and Ingema, Demesel and the Matia Gerontology Institute and has developed a new door or an emergency exit for people who do not have mobility.

PuertaTECNALIAMovReducida

Though emergency exits are easy to open and are very useful when it is necessary to evacuate the building, opening the door by pressing against the bar can be a very difficult process when there is low visibility and depends on the functional capacity and the state of consciousness of users. This door has been developed particularly for hospitals, industrial premises and public areas.

Though in appearance, the new door is like the regular doors that are in use at present, the exit mechanism gets activated when the door detects slight body pressure. The door is fitted with sensors in order to activate the panic exit device. This feature is particularly useful when there is a need to evacuate a large number of people. The final testing for this door was done by a large group of people at the Hospital Bermingham of the Matia Foundation at Basque Country. The users included senior citizens, people from the hospital’s day care and other people with functional impairment and users of wheelchairs. 63.5% users declared that the door was easy to use. The door has achieved EI 90 classification and meets the requirements of legislation in terms of social security and safety.

Source: http://www.basqueresearch.com

Joel Scanlon

Written by

Joel Scanlon

Joel relocated to Australia in 1995 from the United Kingdom and spent five years working in the mining industry as an exploration geotechnician. His role involved utilizing GIS mapping and CAD software. Upon transitioning to the North Coast of NSW, Australia, Joel embarked on a career as a graphic designer at a well-known consultancy firm. Subsequently, he established a successful web services business catering to companies across the eastern seaboard of Australia. It was during this time that he conceived and launched News-Medical.Net. Joel has been an integral part of AZoNetwork since its inception in 2000. Joel possesses a keen interest in exploring the boundaries of technology, comprehending its potential impact on society, and actively engaging with AI-driven solutions and advancements.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Scanlon, Joel. (2019, February 22). Tecnalia Research and Innovation Develops Innovative Door for People with Low Mobility. AZoBuild. Retrieved on November 22, 2024 from https://www.azobuild.com/news.aspx?newsID=15032.

  • MLA

    Scanlon, Joel. "Tecnalia Research and Innovation Develops Innovative Door for People with Low Mobility". AZoBuild. 22 November 2024. <https://www.azobuild.com/news.aspx?newsID=15032>.

  • Chicago

    Scanlon, Joel. "Tecnalia Research and Innovation Develops Innovative Door for People with Low Mobility". AZoBuild. https://www.azobuild.com/news.aspx?newsID=15032. (accessed November 22, 2024).

  • Harvard

    Scanlon, Joel. 2019. Tecnalia Research and Innovation Develops Innovative Door for People with Low Mobility. AZoBuild, viewed 22 November 2024, https://www.azobuild.com/news.aspx?newsID=15032.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.